Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Jun 30, 2026
Novo Nordisk's new study suggests patients prefer its oral Wegovy to Eli Lilly's Foundayo. But what does this mean for the companies and the healthcare market?